RDX013

· Ardelyx

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RDX013, covering 2022-05-04 to 2022-05-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety and Efficacy of RDX013 for the Treatment of Hyperkalemia [Phase 2]